Vendor, Cambridge, MA
Coalesenz Inc.
UEI J2FNAFKMP664, CAGE 8C2V5
2 awards and $549,959 obligated between January 22, 2024 and July 25, 2025, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $549,959 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 2 |
| Small Business Set Aside - Total | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942525CE002Definitive Contract, July 25, 2025, Full and Open Competition After Exclusion of Sources, 1 offers | Army Med Res Acq ActivityDefense Health Agency | Award a Research and Development Small Business Technology Transfer Program Phase II Enhancement Award to Coalesenz, INC for Project Titled,NAICS 541715, PSC AN12 | $549,959 |
| W81XWH20C0119Definitive Contract, January 22, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | W4PZ USA Med RSCH Acquis ActDepartment of the Army | DHA STTR Phase II Medical Research and Development Contract for the Project Titled: Point of Care Blood Coagulopathy DiagnosticsNAICS 541715, PSC AN91 | $0 |
- Places of performance
- Massachusetts
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchAN91 N – Health R&D Services
- Transactions
- 2 across 2 awards